Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • IPO
      • Market News
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • November 2026
        • October 2026
        • September 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Press Release»Sunpure receives patent for Curcuminoids Complex AKTIV C5 (CURCUBOOST®)
    Press Release

    Sunpure receives patent for Curcuminoids Complex AKTIV C5 (CURCUBOOST®)

    WebDeskBy WebDeskAugust 22, 2024No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    New Delhi (India), August 22: Sunpure announced a milestone in its ongoing intellectual property mission. Sunpure has received a patent grant for Curcuminoids Complex AKTIV C5 (CURCUBOOST®) with enhanced bioavailable penta active components of Turmeric.

    “We are thrilled to receive this patent, highlighting our commitment to innovation.  This patent (CURCUBOOST®) grant is a significant milestone for Sunpure Research Incubation Centre (SRIC), Sunpure Extracts Private Limited, and we look forward to bringing more such innovative health solutions and ingredients to our customers”, says Mr. Amit Srivastava (GM), Sunpure.

    The application for the Invention of the Curcumin C5 AKTIV complex—CURCUBOOST® —was accepted in 2019, and after addressing various queries, it was granted in 2024. This patent will be in force until 2039.

    The present invention envisioned chemical composition modification of the active molecules of Turmeric to use Curcuminoids with better Bioavailability and increased efficacy by using two additional ingredients: Turmeric Merone and Polysaccharides along with Curcuminoids, says Mr. Singh, Principal Scientist, SRIC (Sunpure Research Incubation Centre).

    SRIC scientists work tirelessly to discover and develop standardised natural extracts that provide an alternative therapy for emerging nutritional and health requirements worldwide. This patent grant recognises the pioneering work accomplished in the IP domain by the SEPL Team.

    This will benefit formulators economically, as using less CURCUBOOST will increase bioavailability, and enhanced absorption will lead to better efficacy.

    “With its seamless application across various delivery mechanisms, this achievement reaffirms our dedication to pioneering technological integration of Ayurveda and modern science that redefine novel solutions. Our initiatives showcase our proactive commitment to environmental sustainability using whole biomass”, says Mr Saurabh Sharma (VP) of Sunpure.

    The award recognises and celebrates Sunpure’s IP portfolio, which has embraced IP generation and protection to fuel economic growth and contribute to the country’s economic progress.

    Sunpure has GMP certification and an Ayurvedic license from AYUSH.

    About Sunpure Extracts Private Limited (SEPL)

    Sunpure Extracts Private Limited (SEPL) has natural extract production facilities in UP and Uttarakhand and exports natural ingredients to over 32 countries. SEPL is globally known for B2B brands like AshwaBoost®, CurcuBoost®, SPIRUproteen®, MORIMAXproteen®, ZingiNatPure®, BOSWpure®, WKB20K®, TetraBeauty® FENUTEIN®, and CENTpure®. The company has successfully filed 14 US DMFs with the US FDA for a range of natural extracts and Botanicals and has applied for 4 patents. SEPL serves companies in the nutraceuticals, food supplements, pharma, personal care, flavour, and fragrance segments.

    Media Contact:

    Arun

    If you object to the content of this press release, please notify pr.error.rectification@gmail.com. We will get back to you and fix the situation within 24 hours.

    PR press-release
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    WebDesk
    • Website

    Related Posts

    Duroply Showcases its Built-to-Last Legacy

    November 14, 2026

    Austere Systems Announces H1 FY27 Results

    November 14, 2026

    ROX Hi-Tech Announces Unaudited Financial Results for H1 FY27

    November 14, 2026

    Comments are closed.

    Recent Post
    • Duroply Showcases its Built-to-Last Legacy
    • Austere Systems Announces H1 FY27 Results
    • ROX Hi-Tech Announces Unaudited Financial Results for H1 FY27
    • PAN HR Solution Limited Reports H1 FY27 Results
    • Why Colonialism Still Matters: Museum of British Colonialism to Host Online Panel Discussion on 19 November
    • Dr. R. K. Thukral and the Work of Bringing Neuropsychiatry Closer to Patients
    • From Global Recognition to Academic Excellence: LBSIM’s Continuing Journey After AACSB Accreditation
    • DEV Information Technology Reports Q2 FY27 Total Income of Rs. 63.07 Cr, Up 28 Percent YoY; H1 FY27 Total Income Reaches Rs. 107.72 Cr, Up 16 Percent YoY

    Type above and press Enter to search. Press Esc to cancel.